Scholars@Duke
Kathryn Eve Flynn

Kathryn Eve Flynn

Adjunct Professor in the Department of Population Health Sciences
Population Health Sciences
Box 3850 Med Ctr, Durham, NC 27710
2400 Pratt St, Durham, NC 27710

Scholarly Works - Conferences

Evaluation of a remote electronic assessment of survivors with tailored follow-up recommendations and survivorship messaging (REASSURE) to improve the delivery of follow-up for low-risk breast cancer survivors.

Conference Journal of Clinical Oncology · June 1, 2026 1669Background: Current follow-up care for the 2 million+ low-risk breast cancer survivors fails to adequately address survivors’ needs and burdens survivors and oncology teams. We evaluated a novel approach to follow-up that comprehensively assesses survi ... Full text Cite

Reducing effort through informatics-driven identification, recruitment, and data capture on a trial to improve adjuvant endocrine therapy adherence.

Conference Journal of Clinical Oncology · June 1, 2026 11025Background: Adjuvant endocrine therapy (AET) improves outcomes in HR+ breast can ... Full text Cite

QoL: What Do Patients Really Want?

Conference CLINICAL LYMPHOMA MYELOMA & LEUKEMIA · September 2025 Link to item Cite

Sexual Health Outcomes in Sexual Minority and Heterosexual Men After Prostate Radiation Therapy.

Conference Int J Radiat Oncol Biol Phys · June 1, 2025 PURPOSE/OBJECTIVES: To characterize the effects of prostate radiation therapy on sexual health outcomes in sexual minority men (SMM), particularly those engaging in receptive anal intercourse (RAI), and compare them with heterosexual men (HET). METHODS AND ... Full text Link to item Cite

Addressing Colorectal Cancer Among Alaska Native Peoples: A Community and Subject Matter Expert Symposium

Conference Gastro Hep Advances · January 1, 2025 Background and Aims: Alaska Tribal health organizations are working to increase colorectal cancer (CRC) prevention and control as well as awareness of its impact among Alaska Native peoples, who have the highest rates of CRC in the world. Methods: The Alas ... Full text Cite

U.S. Expert Consensus on Defining Intolerance to Tyrosine Kinase Inhibitor Treatment in Chronic Phase Chronic Myeloid Leukemia (CML)

Conference Blood · November 5, 2024 Introduction: The incidence of CML in the United States (U.S) is 1-2 cases per 100,000 persons per year and the prevalence has risen, in part due to the effectiveness of BCR-ABL1 tyrosine ... Full text Cite

First Results of Asciminib As Initial Therapy with Addition of Lower Dose Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia Who Do Not Achieve a Deep Molecular Remission (ALERT CML) from the H Jean Khoury Cure CML Consortium (HJKC3)

Conference Blood · November 5, 2024 Background: Although tyrosine kinase inhibitors (TKIs) have dramatically improved the outcome of patients (pts) with CML, further improvements are needed in efficacy, reduction in AEs, an ... Full text Cite

Impact of Adverse Events on Health-Related Quality of Life in Patients with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKIs) - Early Results of the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study

Conference Blood · November 5, 2024 INTRODUCTION:Patients with chronic phase CML (CP-CML) treated with first- (1G) or second-generation (2G) TKIs as their first or second treatment often ... Full text Cite

Abstract B068: Physical function and fitness of African American prostate cancer survivors at baseline of Men Moving Forward, a lifestyle intervention program

Conference Cancer Epidemiology, Biomarkers & Prevention · September 21, 2024 AbstractBackground: Prostate cancer (PC) is the most commonly diagnosed cancer in American men with 1 in 8 men diagnosed in their lifetime. African American men have the highest rates of incidence and mortal ... Full text Cite

Abstract A106: Examining the role of social connection on allostatic load and quality of life in African American prostate cancer survivors

Conference Cancer Epidemiology, Biomarkers & Prevention · December 1, 2023 AbstractBackground. Racial disparities in prostate cancer (PC) survivorship persist despite clinical advancements. Chronic stress may contribute to these disparities, with allostatic load (AL) considered a m ... Full text Cite

HJKC3-0006: Outcome of Patients with CML Treated on Second Line or Later Therapy in Routine Clinical Practice

Conference Blood · November 2, 2023 Background: First-line therapies for chronic-phase (CP) CML include the tyrosine kinase inhibitors(TKIs) dasatinib, nilotinib, bosutinib or imatinib, while ponatinib and asciminib are indicated only in later lines. Ther ... Full text Cite

HJKC3-007: Outcomes of Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Asciminib and Other Tyrosine Kinase Inhibitors in Routine Clinical Practice

Conference Blood · November 2, 2023 Background and significance: There are typically high response rates to first line TKI therapies in chronic phase chronic myeloid leukemia (CP-CML). However, responses in later lines (second line and beyond) are diminis ... Full text Cite

Patient Priorities in the Treatment of Gallstone Disease: A Qualitative Analysis

Conference JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS · November 2023 Link to item Cite

Abstract B032: Diet quality and physical activity of African American prostate cancer survivors at baseline of Men Moving Forward, a lifestyle intervention program

Conference Cancer Epidemiology, Biomarkers & Prevention · January 1, 2023 AbstractBackground: In the United States, approximately 41,600 new cases of prostate cancer will be diagnosed in Black/African American men in 2022. Lifestyle can impact cancer survivorship, including recurr ... Full text Cite

Abstract A034: Health-related quality of life among African American prostate cancer survivors enrolled in a lifestyle intervention program

Conference Cancer Epidemiology, Biomarkers & Prevention · January 1, 2023 AbstractBackground: Prostate cancer (PC) is the most diagnosed non-skin cancer among men in the United States, with African American (AA) men experiencing the highest incidence of all racial/ethnic groups. S ... Full text Cite

Health-Related Quality of Life in a Biologic Assignment Trial of Reduced Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome

Conference Blood · November 5, 2021 AbstractIntroductionThe Blood and Marrow Transplant Clinical Trials Network study (BMT CTN 1102, NCT02016781) was a multicenter, biologic assignment trial in older adults age ... Full text Cite

Do PROs Tell the Whole Story? Differential Outcomes Based on Patient-Reported Outcomes (PROs) Versus Performance-Based Metrics (PBM) on Cognition for Patients Receiving Chimeric Antigen Receptor (CAR)-T Cell Therapy

Conference Blood · November 5, 2021 AbstractIntroduction: As the use of CAR-T cell therapy grows, there is an increased need to understand its impact on the patient experience, especially symptom burden and cognitive function. While the immedi ... Full text Cite

Worsening Financial Toxicity Among Patients Receiving Chimeric Antigen Receptor t-Cell (CAR-T) Therapy: A Mixed Methods Longitudinal Study

Conference Blood · November 5, 2021 AbstractIntroduction: CAR-T cell therapy is associated with extra-ordinary costs with estimates of as much as $1.5 million in some patients, including the high list-price for the CAR-T product, additional co ... Full text Cite

Prevalence of childhood trauma and its association with lower urinary tract symptoms in women and men in the LURN study.

Conference Neurourol Urodyn · February 2021 AIMS: To describe the association between childhood traumas (death of a family member, severe illness, sexual trauma, parental separation) reported by women and men and lower urinary tract symptoms (LUTS). METHODS: In this secondary analysis of the Lower U ... Full text Link to item Cite

Abstract B006: Developing Men Moving Forward, a lifestyle intervention for African American prostate cancer survivors

Conference Cancer Epidemiology, Biomarkers & Prevention · June 1, 2020 AbstractAfrican American men are disproportionally affected by high prostate cancer incidence and mortality, and also comorbidities. African American prostate cancer survivors (AAPCS) report lower quality of ... Full text Cite

Reliability and validity of PROMIS® pediatric family relationships short form in children 8-17 years of age with chronic disease.

Conference Qual Life Res · January 2020 PURPOSE: Families play a key role in managing pediatric chronic illness. The PROMIS® pediatric family relationships measure was developed primarily within the general pediatric population. We evaluated the Family Relationships short form in the context of ... Full text Link to item Cite

Patient-Reported Outcome Results from the U.S. Life after Stopping TKIs (LAST) Study in Patients with Chronic Myeloid Leukemia

Conference Blood · November 13, 2019 Background: Treatment of chronic myeloid leukemia (CML) with a tyrosine kinase inhibitor (TKI) offers significant improvements over previous treatments in terms of survival and toxicity yet has been associated with reduced health-related quality of ... Full text Cite

Building a National CML Registry

Conference Blood · November 13, 2019 Background:Tyrosine kinase inhibitor (TKI) therapy has led to phenomenal improvement in overall survival for patients with CML. Since TKI therapies were introduced and their results observed, very little innovative ... Full text Cite

Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor (CAR)-T Cell Therapy

Conference Blood · November 13, 2019 CD19-targeted chimeric antigen receptor (CAR)-T cell therapy is a novel treatment with promising results for patients with relapsed/refractory lymphoid malignancies. CAR-T cell therapy has known early toxicities of cytokine release syndrome (CRS) a ... Full text Cite

Psychometric Evaluation of PROMIS Sexual Function and Satisfaction Measures in a Longitudinal Population-Based Cohort of Men With Localized Prostate Cancer.

Conference J Sex Med · December 2018 BACKGROUND: There are multiple treatment options for men with localized prostate cancer that provide similar curative efficacy but differ in their impact on sexual functioning. AIM: To evaluate the psychometric properties of the Patient-Reported Outcomes M ... Full text Link to item Cite

Patients' Perspectives on the Definition of Cure in Chronic Myeloid Leukemia: A US Based Survey

Conference Blood · November 29, 2018 AbstractIntroduction:The development of tyrosine kinase inhibitors (TKIs) has markedly improved the prognosis of patients (pts) with chronic myeloid leukemia (CML), with the ... Full text Cite

Adjuvant Doxycycline to Enhance Anti-Amyloid Effects: Results from the DUAL (Doxycycline to Upgrade response in AL amyloidosis) Study

Conference Blood · November 29, 2018 AbstractBackground: Light chain (AL) amyloidosis is associated with misfolded, insoluble fibril deposits in vital organs such as the heart, kidneys, liver, and nerves, derived from immunoglobulin light chain ... Full text Cite

Decision making by patients seeking care for fertility problems

Conference Fertility and Sterility · September 2016 Full text Cite

Infertility & family-building priorities

Conference Fertility and Sterility · September 2016 Full text Cite

DEVELOPMENT AND PRELIMINARY VALIDATION OF THE PROMIS SEXFS VERSION 2.0

Conference JOURNAL OF SEXUAL MEDICINE · January 1, 2015 Link to item Cite

Significant Variation in Provider Discussion of Sexual Side Effects With Radiation Therapy Patients

Conference International Journal of Radiation Oncology*Biology*Physics · November 2012 Full text Cite

REASONS FOR SEXUAL INACTIVITY: RESULTS FROM A NATIONAL SURVEY

Conference JOURNAL OF SEXUAL MEDICINE · August 1, 2012 Link to item Cite

DEVELOPMENT AND VALIDATION OF THE PROMIS SEXUAL FUNCTION MEASURE

Conference JOURNAL OF SEXUAL MEDICINE · August 1, 2012 Link to item Cite

PATIENTS' UNDERSTANDING OF INTEREST, DESIRE, AND AROUSAL

Conference JOURNAL OF SEXUAL MEDICINE · August 1, 2012 Link to item Cite

Validity of 1-month Recall for Components of Sexual Function (MT)

Conference QUALITY OF LIFE RESEARCH · January 1, 2012 Link to item Cite

Validating the PROMIS (R) Sexual Function Brief Profile Measures

Conference QUALITY OF LIFE RESEARCH · January 1, 2012 Link to item Cite

THE PROMIS (c) SEXUAL FUNCTION MEASURE: DEVELOPMENT AND EARLY VALIDATION

Conference ANNALS OF BEHAVIORAL MEDICINE · April 1, 2011 Link to item Cite

Incorporating item banks into clinical trials: Investigator perceptions

Conference JOURNAL OF GENERAL INTERNAL MEDICINE · April 1, 2007 Link to item Cite